Clinical studies have confirmed that pharmacological agents like dexmedetomidine [63] and metformin [64] can activate the PI3K/Akt pathway, inhibiting pro-inflammatory cytokine release and improving sepsis-associated brain and lung injury. Here, AKT1 is linked to Sepsis.